This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Rochester. Active years: 2017-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017-2020
Title: Innovations of Kai-Dong Zhang in Antimalarial Research
Introduction
Kai-Dong Zhang is a prominent inventor based in Langley, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimalarial agents. With a total of 2 patents, his work focuses on innovative methods for preparing artemisinin derivatives.
Latest Patents
Zhang's latest patents include groundbreaking research on artemisinin derivatives, which are crucial for treating malaria and other parasitic infections. These patents detail the derivatives of the antimalarial agent artemisinin, compositions that comprise these derivatives, and methods for their preparation. The production of artemisinin derivatives is achieved through functionalization of positions C7 and C6a, with optional modifications at positions C10 and C9 using chemoenzymatic methods. Additionally, recombinant cytochrome P450 polypeptides are provided for use in these methods. The artemisinin derivatives can be utilized alone or in combination with other antiparasitic drugs for effective treatment.
Career Highlights
Kai-Dong Zhang is affiliated with the University of Rochester, where he continues to advance his research in pharmaceutical sciences. His work has garnered attention for its potential impact on public health, particularly in combating malaria.
Collaborations
Zhang collaborates with Rudi Fasan, enhancing the scope and depth of his research endeavors. Their partnership aims to further explore the applications of artemisinin derivatives in medical treatments.
Conclusion
Kai-Dong Zhang's innovative work in the field of antimalarial research exemplifies the importance of scientific advancements in combating infectious diseases. His contributions through patents and collaborations continue to pave the way for new therapeutic options.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
